Related Experiment Videos
Treatment of pseudophakic CME
1Barnes Retina Institute, St. Louis, MO 63110, USA. nholekamp@pol.net
Ocular Immunology and Inflammation
|August 5, 1998
Summary
Pseudophakic cystoid macular edema (PCME) is a common complication of cataract surgery. Despite advances, effective treatments for chronic PCME remain elusive, highlighting a need for further research.
Area of Science:
- Ophthalmology
- Surgical Complications
- Macular Edema
Background:
- Pseudophakic cystoid macular edema (PCME) is a recognized complication of cataract surgery.
- Despite its long-standing recognition, the pathogenesis of PCME is poorly understood.
- The high prevalence of cataract surgery results in a significant number of PCME cases.
Purpose of the Study:
- To review the current understanding of pseudophakic cystoid macular edema.
- To discuss the challenges in treating chronic visually significant PCME.
- To emphasize the need for advancements in PCME management.
Main Methods:
- Literature review of PCME pathogenesis and treatment.
- Analysis of the efficacy of current therapeutic options.
- Evaluation of surgical interventions like vitrectomy.
Main Results:
- Acute PCME may resolve spontaneously, but chronic forms are difficult to treat.
- Current medical treatments, including NSAIDs and corticosteroids, show limited success.
- Vitrectomy surgery can improve outcomes in select cases with vitreous abnormalities or refractory disease.
Conclusions:
- There is a significant unmet need for improved understanding of PCME pathogenesis.
- Novel and more effective treatment strategies for chronic PCME are required.
- Further research is essential to advance the management of this complication.